[Dose-dense paclitaxel plus carboplatin in combination with trastuzumab neoadjuvant versus standard adjuvant therapy in human epidermal growth factor receptor-2 positive and hormone receptor negative breast cancer: a prospective cohort study].
Zhonghua Zhong Liu Za Zhi
; 45(8): 709-716, 2023 Aug 23.
Article
in Zh
| MEDLINE
| ID: mdl-37580278
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carboplatin
/
Paclitaxel
/
Triple Negative Breast Neoplasms
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
Zh
Journal:
Zhonghua Zhong Liu Za Zhi
Year:
2023
Type:
Article
Affiliation country:
China